Asset Details
Do you wish to reserve the book?
Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles
Do you wish to request the book?
Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles
2024
Overview
Atherosclerosis, a multifaceted chronic inflammatory disease, has a profound impact on cardiovascular health. However, the critical limitations of atherosclerosis management include the delayed detection of advanced stages, the intricate assessment of plaque stability, and the absence of efficacious therapeutic strategies. Nanotheranostic based on nanotechnology offers a novel paradigm for addressing these challenges by amalgamating advanced imaging capabilities with targeted therapeutic interventions. Meanwhile, iron oxide nanoparticles have emerged as compelling candidates for theranostic applications in atherosclerosis due to their magnetic resonance imaging capability and biosafety. This review delineates the current state and prospects of iron oxide nanoparticle‐based nanotheranostics in the realm of atherosclerosis, including pivotal aspects of atherosclerosis development, the pertinent targeting strategies involved in disease pathogenesis, and the diagnostic and therapeutic roles of iron oxide nanoparticles. Furthermore, this review provides a comprehensive overview of theranostic nanomedicine approaches employing iron oxide nanoparticles, encompassing chemical therapy, physical stimulation therapy, and biological therapy. Finally, this review proposes and discusses the challenges and prospects associated with translating these innovative strategies into clinically viable anti‐atherosclerosis interventions. In conclusion, this review offers new insights into the future of atherosclerosis theranostic, showcasing the remarkable potential of iron oxide‐based nanoparticles as versatile tools in the battle against atherosclerosis. This review mainly focuses on the advances and prospects in the iron oxide nanoparticles‐based atherosclerosis theranostics, which may simultaneously possess targeting, diagnostic, and therapeutic functions. A comprehensive and detailed summary of related researches are provided according to three therapeutic strategies, encompassing the chemical therapy, physical stimulation therapy, and biologic therapy.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc,Wiley
